focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Nickname, why such avatar, are you looking for a nickname? How about Eroxon since you seem to be in ´love’ with the company for no reason hence your multiple avatars. Or Mr. Erection Dysfunction. Or better still Mr. Brain Dysfunction?
I think liquidity must be getting pretty tight as peeps are accumulating and will hold for the story to unfold.
This will suddenly start to move up the minute our big investors have completed their fill.
Statins are sourced from a simple fungi, are 3% effective and have serious side effects. Yet they generate over £20bn profit per year are the most profitable pharmaceutical product of ALL TIME !!!!!
...So Nickname (Liam?)
FUM tested
Europe CE accredited
Approved by FDA (Via extended study)
Approved by NICE for NHS
Due diligence by Atlantis Grp
Due diligence by Coopers
Due diligence by Haleon
Won Boots best product award
All these people got it wrong, it was a placebo effect after all, the daft people could not see it! .....And you did!
What a clever person you are.
Good find - 5 outlets already linked in and progress!
Nickname......hello...are you liam booth.....
"Nic…. Yes I do…"
Tried tadalafil?
Any PR savvy company would milk any SP affecting news, ie addition of a new country outlet. We hear it through the BB!
Am I missing something or is the company 'missing a trick'?
I've just checked FUM's website and they have added Norway to their list and it's avaible there. Still not avilable in Portugal and Italy...but the list is growing....
FUM tested
Europe CE accredited
Approved by FDA (Via extended study)
Approved by NICE for NHS
Due diligence by Atlantis Grp
Due diligence by Coopers
Due diligence by Haleon
Won Boots best product award
Vs
'Suspect' Boots feedback. (Do the math!)
Even if a small percentage of the established ED success rate is converted to sale + NHS users (UK) + the recreational users (which I feel will turnout to be the largest user group, in future), this will be BIG.
Someone mentioned L/O (Largest share holder 28.5%) exit strategy. IMO Don't hold your breath. This is a growth fund now.
I have no doubts that this is going to be a very popular product, whether one suffers from diagnosed ED, or not.
Apart from the ED market, There are numerous occasions whereby perfectly young & healthy men have erection issues, stress, overtired, ‘stage fright’ with a new partner, too much alcohol etc etc.
Having some gel handy, aswell as a condom or 2, will become the norm.
In regards to the reviews, The NHS has approved the product for prescription, so it has already undergone strict approval processes proving its effectiveness.
My interest at this stage is how much FUM is going to be worth within 6, 12, 18 months time?
If annual sales accelerate and Eroxon takes a minimum of 20% of the Global market (£4.7Bn) then consider our MCap then.
Personally, being able to buy OTC & use a product like Eroxon, that works within 10 minutes, without side effects, will Trump products that take an hour, such as Viagra, with a number of well documented side effects, plus an interview before one can purchase it.
So, I consider our market will gain increasing traction and eventual sales will be phenomenal.
Has anyone here actually tried the gel where they can say that the gel changed and improved the feelings down below much for the better. This aspect hardly gets discussed but it opens a new line of business for those men who simply want a more enjoyable experience even if they do not have ED. My sense is that very much can if you have the basic sensitivity in place. So you could in theory sell this to a single man for solo s e x
Nic…. Yes I do… and the gel works well for me…side affect free.. unlike vardenafil which leaves me with a headache hangover feeling the next day……
"No….. but she does have some sensitive areas that liked the gel…… and it gave her something a little extra/ different…."
And I'm guessing you don't have ED either, would that be correct?
Spahawk,you need ro read the formal RNSs regarding results etc. you will find it has proven effective in approximately 60/65% of users.it has never been claimed to work for everyone .the point is that it has been shown to work for a majority of users and on that basis the negative reviews need to be seen as not reflective of the majority of real world users. imo
Sparhawk-
The reviews on Boots have been discussed on this BB several times. It was also mentioned by Mr Barder. He said most of the negative reviews seemed contrived.
Look at repetitive language used. The constant reference to the blue pill and waste of money etc.
This product may have the potential to take a massive market share from the established brands.
It's not a welcome product for some.
It's quite possible that the reviews are fake. The competitor product doesn't have anywhere near as many reviews. In fact no other boots product has that many reviews.
We generally take it as a good sign which means the competition is worried.
But please do you're own alternative research and come up with you're own conclusion.
I was thinking of investing, but their main product Eroxon only seems to work in 1 case in 4 according to over 400 reviews, is this what was indicated in the clinical trials?
https://www.boots.com/eroxon-erectile-dysfunction-treatment-gel-4-pack-10327183
Franlian, its a mug's game to predict s/ps, as there are so many unknowns and possible variables. however, as you have asked,my own personal prediction is that ultimately Fum will be taken over in some way,as i see this as L/O's only realistic exit strategy. i do not think this will be for less than 100p per share. purely personal opinion and no advice intended whatsoever. good luck with you investment..
I’m a new investor here and plan to stay for the long term . For those more savvy about these things what are your personal expectations on share price when the US markets and the others recently commissioned start to sell stock . Would be nice to know what others are thinking if we get the big sales .
When are the final results? April? Sorry I’m too lazy at the moment to check lol
Anyone having same problem this morning?
When results were issued last year there was a video which mentioned future revenue in 2025 when US sales take off with a prediction of £400 million. Work it out everyone it dosnt take Einstein to work out the possible SP and to be honest FUM aren’t great at blowing their own trumpet so this figure will be on the pessimistic side if anything. IMO £1billion valuation is somewhere near for just Eroxon alone, we also have to consider the possible value of the products put on hold to focus on Eroxon.
The sticky SP is down to the Bots exercising their control atm, I suspect some clever clogs is accumulating a shed load, and whilst that’s underway, the AT algobots put the brakes on any potential upward movement.
We’ll see how long it lasts , but meanwhile, in the background, rollout continues, sales build, and at some point this will start flying.
The problem with Haleon is that it's not GSK in name now.
If the RNS was that GSK has were distributing it, the share would have gone through the roof.
I'm pleased about this though as it's kept the SP low for me to get in, and the real value in Haleon is the sales they willa chieve. So it just means we have to wait for the £££££'s in updates to push the re rate instead..
Dr Rena Maliks eroxon clip still climbing ...had a look at some other clips and some are 10 to 13 million with one getting 29 million
( No clues for guessing which one that is but had nothing to do with any types of ED products )
A clip for Sidifenal vs Tadalafil got 8 million two years ago but looks like the eroxon one might go higher